Reports on The FDA’s Approval of Zeposia as a New Disease-Modifying Therapy
Mar 30, 2020, 12:00 AM
Share
Subscribe
MS News Today columnist and forums moderator Ed Tobias reports on the FDA’s approval of Zeposia as a new disease-modifying therapy.
Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
